Regulation of tyrosine phosphatases in the adventitia during vascular remodelling

Biochemical and Biophysical Research Communications

Volumn 382, Issue 4, 2009, Pages 678-684

  Micke, Patrick ^a,b   Hackbusch, Daniel ^c   Mercan, Sibel ^c   Stawowy, Philipp ^d   Tsuprykov, Oleg ^c   Unger, Thomas ^c   Östman, Arne ^a   Kappert, Kai ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Adventitia; Growth factors; Neointima; Platelet derived growth factor; Protein tyrosine phosphatase; Restenosis; Tissue remodelling

Indexed keywords

DEP 1 PROTEIN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

ADVENTITIA; ANGIOPLASTY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REGULATION; GENE EXPRESSION; LASER MICRODISSECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR UPREGULATION;

ANIMALS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL PROLIFERATION; CONNECTIVE TISSUE; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; MODELS, ANIMAL; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REGENERATION; SIGNAL TRANSDUCTION;

RATTUS;

EID: 64749104735     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.078     Document Type: Article

References (26)

1. Gershlick A.H. Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials. Atherosclerosis 160 (2002) 259-271
2. Andrae J., Gallini R., and Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22 (2008) 1276-1312
3. Heldin C.H., Eriksson U., and Ostman A. New members of the platelet-derived growth factor family of mitogens. Arch. Biochem. Biophys. 398 (2002) 284-290
4. Kappert K., Peters K.G., Bohmer F.D., and Ostman A. Tyrosine phosphatases in vessel wall signaling. Cardiovasc. Res. 65 (2005) 587-598
5. Kappert K., Paulsson J., Sparwel J., Leppanen O., Hellberg C., Ostman A., and Micke P. Dynamic changes in the expression of DEP-1 and other PDGF receptor-antagonizing PTPs during onset and termination of neointima formation. FASEB J. 21 (2007) 523-534
6. Markova B., Herrlich P., Ronnstrand L., and Bohmer F.D. Identification of protein tyrosine phosphatases associating with the PDGF receptor. Biochemistry 42 (2003) 2691-2699
7. Uchida K., Sasahara M., Morigami N., Hazama F., and Kinoshita M. Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries. Atherosclerosis 124 (1996) 9-23
8. Uzui H., Lee J.D., Shimizu H., Tsutani H., and Ueda T. The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis 149 (2000) 51-59
9. Chang Y., Ceacareanu B., Zhuang D., Zhang C., Pu Q., Ceacareanu A.C., and Hassid A. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 501-507
10. Kappert K., Sparwel J., Sandin A., Seiler A., Siebolts U., Leppanen O., Rosenkranz S., and Ostman A. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2644-2651
11. Zhuang D., Pu Q., Ceacareanu B., Chang Y., Dixit M., and Hassid A. Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B. Am. J. Physiol. Heart Circ. Physiol. 295 (2008) 163-173
12. Castiglioni S., Maier J.A., and Mariotti M. The tyrosine phosphatase HD-PTP: A novel player in endothelial migration. Biochem. Biophys. Res. Commun. 364 (2007) 534-539
13. Xu F., Ji J., Li L., Chen R., and Hu W.C. Adventitial fibroblasts are activated in the early stages of atherosclerosis in the apolipoprotein E knockout mouse. Biochem. Biophys. Res. Commun. 352 (2007) 681-688
14. Siow R.C., Mallawaarachchi C.M., and Weissberg P.L. Migration of adventitial myofibroblasts following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries. Cardiovasc. Res. 59 (2003) 212-221
15. Hoshino A., Chiba H., Nagai K., Ishii G., and Ochiai A. Human vascular adventitial fibroblasts contain mesenchymal stem/progenitor cells. Biochem. Biophys. Res. Commun. 368 (2008) 305-310
16. Siow R.C., and Churchman A.T. Adventitial growth factor signalling and vascular remodelling: potential of perivascular gene transfer from the outside-in. Cardiovasc. Res. 75 (2007) 659-668
17. Chang Y., Zhuang D., Zhang C., and Hassid A. Increase of PTP levels in vascular injury and in cultured aortic smooth muscle cells treated with specific growth factors. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H2201-H2208
18. Clowes A.W., Reidy M.A., and Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49 (1983) 327-333
19. Myllarniemi M., Frosen J., Calderon Ramirez L.G., Buchdunger E., Lemstrom K., and Hayry P. Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo. Cardiovasc. Drugs Ther. 13 (1999) 159-168
20. Scott N.A., Cipolla G.D., Ross C.E., Dunn B., Martin F.H., Simonet L., and Wilcox J.N. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 (1996) 2178-2187
21. Chen J., Han Y., Lin C., Zhen Y., Song X., Teng S., Chen C., Chen Y., Zhang Y., and Hui R. PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury. Biochem. Biophys. Res. Commun. 329 (2005) 976-983
22. Barrett T.B., and Benditt E.P. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc. Natl. Acad. Sci. USA 85 (1988) 2810-2814
23. Resink T.J., Scott-Burden T., Hahn A.W., Rouge M., Hosang M., Powell J.S., and Buhler F.R. Specific growth stimulation of cultured smooth muscle cells from spontaneously hypertensive rats by platelet-derived growth factor A-chain homodimer. Cell Regul. 1 (1990) 821-831
24. Taki K., Tsuruta Y., and Niwa T. Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients. Am. J. Nephrol. 27 (2007) 30-35
25. Yamamoto H., Tsuruoka S., Ioka T., Ando H., Ito C., Akimoto T., Fujimura A., Asano Y., and Kusano E. Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int. 69 (2006) 1780-1785
26. Persson C., Savenhed C., Bourdeau A., Tremblay M.L., Markova B., Bohmer F.D., Haj F.G., Neel B.G., Elson A., Heldin C.H., Ronnstrand L., Ostman A., and Hellberg C. Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase. Mol. Cell. Biol. 24 (2004) 2190-2201